BeiGene
BGNE
#934
Rank
$21.05 B
Marketcap
$189.23
Share price
-2.10%
Change (1 day)
-6.13%
Change (1 year)
BeiGene is a Chinese pharmaceutical company engaged in the R&D, and commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Stock price history for BeiGene (BGNE)

Highest end of day price: $403.14 USD on 2021-09-17

Lowest end of day price: $23.98 USD on 2016-02-12

Stock price history of BeiGene from 2016 to 2024

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
$1.00-0.47%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.64 1.23%๐Ÿ‡บ๐Ÿ‡ธ USA